Leading the Fight to treat and cure Tay-Sachs, Canavan and related diseases
A bone marrow transplant (BMT), replaces an affected person’s bone marrow with donor marrow that can produce the missing
enzyme. The procedure is risky, invasive and has had very little success in Tay-Sachs, Sandhoff and GM-1. If done early enough it can be effective in slowing and even stopping the disease in other allied diseases like Krabbe and MPS.
Currently only two centers in the US will consider Tay-Sachs, Sandhoff and GM-1 patients for BMT: Duke University Medical Center and University of Minnesota. The Duke program is not an approved clinical trial (contact June Allison-Thacker at
to learn more).
Bone Marrow Transplant is very invasive. Children often succumb to complications of the procedure. The immune system must be completely destroyed before introducing the healthy bone marrow. It is unclear how many of the healthy stem cells cross into the
central nervous system. Learn more:http://www.nlm.nih.gov/medlineplus/ency/article/003009.htmhttp://www.bmtinfonet.org/
National Tay-Sachs & Allied Diseases Association2001 Beacon StreetSuite 204Boston, MA 02135
email@example.com phone617-277-0134 fax
Make a Gift
HomeAbout NTSADMission & VisionBoard of DirectorsStaff & ProfilesChapters & AffiliatesScientific Advisory CommitteeFinancialsOur HistoryNewsLibrary DocumentsGlossaryContactSearchMember Login